These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9175098)

  • 1. High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture.
    Farhangrazi ZS; Ying H; Bu G; Dugan LL; Fagan AM; Choi DW; Holtzman DM
    Neuroreport; 1997 Mar; 8(5):1127-30. PubMed ID: 9175098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.
    Drouet B; Fifre A; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Guéant JL; Chambaz J; Pillot T
    J Neurochem; 2001 Jan; 76(1):117-27. PubMed ID: 11145984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype.
    Verbeek MM; Van Nostrand WE; Otte-Höller I; Wesseling P; De Waal RM
    Ann N Y Acad Sci; 2000 Apr; 903():187-99. PubMed ID: 10818507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein.
    Nathan BP; Jiang Y; Wong GK; Shen F; Brewer GJ; Struble RG
    Brain Res; 2002 Feb; 928(1-2):96-105. PubMed ID: 11844476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity.
    Maezawa I; Jin LW; Woltjer RL; Maeda N; Martin GM; Montine TJ; Montine KS
    J Neurochem; 2004 Dec; 91(6):1312-21. PubMed ID: 15584908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
    Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
    Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
    Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW
    J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures.
    Puttfarcken PS; Manelli AM; Falduto MT; Getz GS; LaDu MJ
    J Neurochem; 1997 Feb; 68(2):760-9. PubMed ID: 9003067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
    Mulder M; Terwel D
    Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.
    DeMattos RB; Brendza RP; Heuser JE; Kierson M; Cirrito JR; Fryer J; Sullivan PM; Fagan AM; Han X; Holtzman DM
    Neurochem Int; 2001; 39(5-6):415-25. PubMed ID: 11578777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
    Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
    J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.
    Padayachee ER; Zetterberg H; Portelius E; Borén J; Molinuevo JL; Andreasen N; Cukalevski R; Linse S; Blennow K; Andreasson U
    Brain Res; 2016 Nov; 1651():11-16. PubMed ID: 27653981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
    Irizarry MC; Rebeck GW; Cheung B; Bales K; Paul SM; Holzman D; Hyman BT
    Ann N Y Acad Sci; 2000; 920():171-8. PubMed ID: 11193147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.